Summary
Though myocardial alterations are well recognized in haemochromatosis, little attention has been paid to the cardiac changes in Wilson's disease. To define the extent of myocardial degeneration in newly diagnosed or chronically treated Wilson's disease, we reviewed the autopsy findings in 9 cases with this condition. We compared our observations with those in 3 control cases, selected for comparable age and with liver disease having no known association with cardiac degeneration. Our results revealed cardiac hypertrophy in 5 out of 9 cases of Wilson's disease. There was evidence of interstitial and replacement fibrosis, intramyocardial small vessel sclerosis and focal inflammatory cell inflammation to a variable degree in all cases. One case had AV nodal degeneration, and a 15 year old boy had severe atherosclerosis of the left main coronary artery. Two patients died suddenly, presumably secondary to an arrhythmia; one of these patients had the most marked myocardial alterations. We could not correlate these changes specifically with the tissue levels of copper, treatment with D-penicillamine, or the presence of cirrhosis. We conclude that there are definite morphological abnormalities in the hearts of patients with Wilson's disease consistent with a cardiomyopathy. Though the myocardial changes were non-specific, the fact that 2 patients died suddenly, suggests the need for a prospective study of cardiac function in these patients in the future.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arnett EN, Nienhuis AW, Henry WL, Ferrans VJ, Redwood DR, Roberts WC (1975) Massive myocardial hemosiderosis: A structure-function conference at the National Heart and Lung Institute. Am Heart J 90:777–787
Azevedo EM, Scaff M, Barbosa ER, Gouveia Neto AE, Canelas HM (1978) Heart involvement in hepatolentricular degeneration. Acta Neurol Scand 58:296–303
Bottiger LE, Mollerberg H (1959) Increased copper content of hypertrophic myocardium. Acta Med Scand 165:413–416
Brandt G (1972) Zur Diagnose der abdominellen Form des Morbus Wilson. Dtsch Med Wochenschr 97:2006–2009
Buja LM, Roberts WC (1971) Iron in the heart. Etiology and clinical significance. Am J Med 51:209–221
Butt EM, Nusbaum RE, Gilmour TC, Didio SL (1958) Trace metal patterns in disease states. II. Copper storage diseases, with consideration of juvenile cirrhosis, Wilson's disease, and hepatic copper of the newborn. Am J Clin Pathol 30:479–497
Factor SM (1976) Intramyocardial small-vessel disease in chronic alcoholism. Am Heart J 92:561–575
Factor SM, Minase T, Sonnenblick EH (1980) Clinical and morphological features of human hypertensive-diabetic cardiomyopathy. Am Heart J 99:446–458
Fell GS, Smith H, Howie RA (1968) Neutron activation analysis for copper in biological material applied to Wilson's disease. J Clin Pathol 21:8–11
Goldfischer S, Sternlieb I (1968) Changes in the distribution of hepatic copper in relation to the progression of Wilson's disease (hepatolenticular degeneration). Am J Pathol 53:883–901
Goldfischer S, Popper H, Sternlieb I (1980) The significance of variations in the distribution of copper in liver disease. Am J Pathol 99:715–730
Irons RD, Schenk EA, Lee JCK (1977) Cytochemical methods for copper. Arch Pathol Lab Med 101:298–301
Kaduk B, Metze K, Schmidt P-F, Brandt G (1980) Secondary athrocytotic cardiomyopathy — heart damage due to Wilson's disease. Virchows Arch [Pathol Anat] 387:67–80
Khan MY, Buse M, Louria DB (1977) Lead cardiomyopathy in mice. A correlative ultrastructural and blood level study. Arch Pathol Lab Med 101:89–94
Koss J, Factor SM (1979) Diabetes mellitus, malabsorption, and congestive heart failure in a middle-aged man. A case of thesaurosclerosis. Am Heart J 98:777–787
Lindquist RR (1969) Studies on the pathogenesis of hepatolenticular degeneration. II. Cytochemical methods for the localization of copper. Arch Pathol 87:370–379
Morell AG, Windsor J, Sternlieb I, Scheinberg IH (1968) Spectroscopic determination of microgram quantities of copper in biologic materials. In: Sunderman FW, Sunderman FW Jr (eds) Laboratory diagnosis of liver diseases. WH Green, St Louis pp 196–198
Nicholas G, Bouhour JB, Delajartre A, Goldin JF, Horeau J (1971) Myocardiopathie secondaire a l'hemochromatose idiopathique. Quatre observations anatome-cliniques avec etude du myocarde en microscopie electronique. Arch Mal Coeur 64:1533–1546
Olsen EGJ (1972) Histochemical, ultrastructural and structural changes in primary cardiomyopathy and in cobalt cardiomyopathy. Postgrad Med J 48:760–762
Olsen EGJ (1979) The pathology of cardiomyopathies. A critical analysis. Am Heart J 98:385–392
Roberts WC, Ferrans VJ (1975) Pathologic anatomy of the cardiomyopathies. Idiopathic dilated and hypertrophic types, infiltrative types and endomyocardial disease with and without eosinophilia. Hum Pathol 6:287–342
Sass-Kortsak A (1965) Copper metabolism. Adv Clin Chem 8:1–67
Scheinberg IH, Sternlieb I (1965) Wilson's disease. Ann Rev Med 16:119–134
Uzman LL (1956) Histochemical localization of copper with rubeanic acid. Lab Invest 5:299–305
Vigorita VJ, Hutchins GM (1979) Cardiac conduction system in hemochromatosis: Clinical and pathological features of six patients. Am J Cardiol 44:418–423
Author information
Authors and Affiliations
Additional information
Supported in part by NIH Grants HL 21756 and NIAMD 17702, and The Foundation for the Study of Wilson's Disease, Inc.
Rights and permissions
About this article
Cite this article
Factor, S.M., Cho, S., Sternlieb, I. et al. The cardiomyopathy of Wilson's disease. Virchows Arch. A Path. Anat. and Histol. 397, 301–311 (1982). https://doi.org/10.1007/BF00496571
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00496571